Page last updated: 2024-11-04

sulfinpyrazone and Renal Insufficiency

sulfinpyrazone has been researched along with Renal Insufficiency in 1 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Catalano, C1
Fabbian, F1
Bordin, V1
Di Landro, D1

Other Studies

1 other study available for sulfinpyrazone and Renal Insufficiency

ArticleYear
Mycophenolate mofetil toxicity in an anorexic kidney transplant patient treated with sulphinpirazone.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1997, Volume: 12, Issue:11

    Topics: Anorexia; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Middl

1997